share_log

港股午评 | 三大指数均跌超2%,抗疫概念股走高,腾盛博药涨超6%

Hong Kong Stock Afternoon Review | All three major indices fell more than 2%, anti-epidemic concept stocks rose higher, and Tenshengbo Pharmaceutical rose more than 6%

富途資訊 ·  Nov 26, 2021 12:10

Futu Information on November 26 | the three major indexes of Hong Kong stocks opened low in the morning, with the Hang Seng Index down 2.13% and more than 500 points, the National Index down 2.08% and the Hang Seng Technology Index down 2.58%.

By midday's close, Hong Kong stocks were up 408, down 1330, to close flat at 1095.

On the plate side, most technology stocks fell.Kuaishou Technology fell by more than 6%, Meituan by nearly 4%, Tencent by more than 3%, BABA by nearly 3%, XIAOMI and B stations by nearly 2%.

The biotechnology sector rose.Tengsheng Boyao-B rose by more than 6%, Conoya-B and Wuxi Apptec by more than 3%, Chuangsheng Group by more than 2%, and Genscript Biotech Corporation by more than 1%.

Internet medical stocks fell.Alibaba Health Information Technology fell by more than 4%, Ping An Healthcare And Technology by more than 3%, Zhongan Online by more than 2%, and JD Health by more than 1%.

Gambling stocks fell across the board.Sands China and Galaxy Entertainment fell more than 5%, SJM Holdings and MGM China fell more than 4%, Wynn Macau fell nearly 4%, and Melco International Development fell nearly 3%.

OLED concept, pharmaceutical outsourcing concept, home appliance stocks rose, Evergrande concept stocks, tobacco concept stocks, aviation stocks fell at the top.

Individual stocks$Tencent (00700.HK) $Down more than 3%, it is reported that from March 1 next year, Wechat, Alipay personal collection code can not be used for business collection.

$Meituan-W (03690.HK) $It fell nearly 4%, and the results will be announced in after-hours trading today.

$Sihuan Medicine (00460.HK) $Rise to more than 3%, Pirosini new III clinical approval, more than 10 new drugs are under clinical trial.

$Seijing Technology (00580.HK) $The turnover exceeded 350 million Hong Kong dollars, and the self-developed products received the first batch order.

$Tengshengbo Medicine-B (02137.HK) $With an increase of more than 6%, COVID-19 's clinical Ⅲ data have been revealed and are expected to be approved for listing by the end of December.

Poly Xiexin Energy (03800.HK) $Photovoltaic stocks fell by more than 6%, and rooftop photovoltaic power generation projects were suspended in many places.

$E-residence Enterprise Holdings (02048.HK) $It rose by more than 7% again, up nearly 60% in two days, and completed the acquisition of the equity stake in the joint venture TM Home.

$Mobile Card (09923.HK) $It has soared more than 12%, and Wechat's personal collection code will not be able to be used for operational collection from March 1.

UBS: to$Xiansheng Pharmaceutical Co. (02096.HK) $With a "buy" rating, the target price rises to HK $11.8.

UBS released a research report that gave Xiansheng a "buy" rating, and KN035 was officially approved by the State Drug Administration for listing, which is expected to generate peak sales of up to 1.5 billion yuan, and raised its forecast point of sale of the product from 75% to 100%. The target price rose from HK $10.8 to HK $11.8.

Macquarie: maintenance$Chinese Education Holdings (00839.HK) $"outperform the market" rating, the target price was reduced to HK $23.5.

Macquarie released a research report to maintain the "outperform" rating of Zhongjiao Holdings, thanks to vocational education policies and industry consolidation, and the group has a strong balance sheet, raising its earnings forecast for 2022-23 by 0.9% and 0.5%. However, the target price has been reduced from HK $24 to HK $23.50, which has taken into account the rights issue.

Half-day turnover TOP20

Edit / irisz

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment